NCT02523014 2026-06-02Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive MeningiomasAlliance for Clinical Trials in OncologyPhase 2 Recruiting124 enrolled